10-K: Target Group Inc. Reports 2025 Loss Amid Revenue Decline

Target Group Inc. reported a significant net loss and revenue decline in its 2025 annual filing, alongside a growing working capital deficit and going concern doubts.

Summary

• A net loss of $1,359,682 was reported for the year ended December 31, 2025, a significant reversal from the net income of $160,504 in 2024.
• Revenue decreased by approximately 41% to $3,881,003 in 2025 from $6,591,625 in 2024.
• The working capital deficit increased to $11,052,097 in 2025 from $9,994,548 in 2024.
• The accumulated deficit grew to $32,306,526 in 2025 from $30,946,844 in 2024.
• Cash and restricted cash plummeted to $108,800 in 2025 from $1,877,759 in 2024.
• Independent auditors issued a report raising substantial doubt about the company's ability to continue as a going concern.
• The company is in breach of a loan agreement with a related party as of December 31, 2025, leading to the reclassification of the entire outstanding balance to current liabilities.
• All warrants expired during 2025, with none being exercised.
• CannaKorp's patent-pending Wisp and Wisp Pods system patents are unmaintained due to missed annuity payments, and management is assessing their value.
• The joint venture agreement with JVCo was terminated on April 27, 2023, resulting in Canary's equity interest in JVCo increasing to 100%.

Sentiment

Score: 2

Explanation: StockSavvy.ai views this filing negatively due to significant financial deterioration, including a net loss, substantial revenue decline, increased working capital deficit, and a going concern warning from auditors. The breach of a related party loan agreement and unmaintained intellectual property further compound the concerns.

Positives

• The company continues to cultivate and sell cannabis products within the Canadian wholesale cannabis market from its Simcoe Facility.
• A strategic partnership with Dutch breeder Serious Seeds B.V. allows for the cultivation of exclusive, proprietary cannabis genetics.
• CannaKorp Inc. holds international and U.S. provisional patents for its vaporizer and pod system, along with proprietary trade names and formulas (though patents are currently unmaintained).
• Management anticipates that future operations will generate positive cash flows starting in 2026.
• The company successfully received all outstanding principal and interest from a convertible note receivable with Alma Cannabis PTY LTD during 2025.

Negatives

• A net loss of $1,359,682 was reported for 2025, a significant decline from net income of $160,504 in 2024.
• Revenue decreased substantially by approximately 41% from $6,591,625 in 2024 to $3,881,003 in 2025.
• The working capital deficit worsened, increasing by over $1 million to $11,052,097 in 2025.
• The accumulated deficit continued to grow, reaching $32,306,526.
• Cash and restricted cash balances decreased dramatically from $1,877,759 in 2024 to $108,800 in 2025.
• Independent auditors raised substantial doubt about the company's ability to continue as a going concern.
• The company is in breach of a related party loan agreement as of year-end 2025, leading to the reclassification of the entire outstanding balance to current liabilities.
• Operating activities used $842,425 in cash in 2025, a reversal from providing $2,162,684 in 2024.
• CannaKorp's key patents are unmaintained due to missed annuity payments, and management is evaluating their value.
• Legal proceedings include a $1.5 million lawsuit from a terminated employee, a $150,000 claim from a former CFO, and a $100,795 claim from a vendor.
• Commitments under the Serious Seeds agreement, including the issuance of shares and warrants and payment of royalties, have not been fulfilled.
• Management concluded that internal control over financial reporting and disclosure controls and procedures were not effective as of December 31, 2025.

Risks

• The business is dependent on state laws pertaining to the marijuana industry, which are uncertain and subject to change, potentially restricting or eliminating operations.
• Cannabis remains illegal under U.S. federal law, which may negatively impact potential U.S. business activities and poses federal enforcement risk even with state-level legalization.
• Laws and regulations affecting the cannabis industry are constantly changing, requiring substantial compliance costs and potentially altering business plans.
• Potential customers may have difficulty accessing U.S. banking services due to the federal illegality of cannabis, hindering their operations.
• The company faces intense competition from entities with longer operational histories, greater financial resources, and larger client bases.
• Uncertainty surrounding the rescheduling of marijuana from Schedule I to Schedule III could lower barriers to entry for well-capitalized institutional competitors, adversely affecting market share and profitability.
• The narrowing of the federal definition of hemp, effective November 12, 2026, could impact licensees in the United States.
• The Canadian cannabis market is subject to an evolving and complex regulatory framework, including oversupply, price compression, consolidation, and competition from the illicit market.
• There is a risk that Canadian licenses may not be renewed on acceptable terms, or that Health Canada may impose additional conditions or enforcement actions.
• The Canadian federal excise duty framework is a persistent source of margin pressure for licensed producers.
• The recreational adult-use cannabis market in Canada may experience periods of oversupply, leading to lower market prices, increased price competition, and reduced margins.
• The company's cannabis cultivation business is subject to agricultural risks such as crop failure, plant diseases, and insects, despite indoor growing conditions.
• Inability to attract or retain key personnel with sufficient experience in the cannabis industry, or to obtain/renew required security clearances, could prevent business plan execution.
• Exposure to counterparty credit risk due to industry consolidation and potential financial distress of third-party relationships.
• Increased risk of information and security breaches due to the growing sophistication of cyber attacks, potentially leading to system disruption or theft of confidential information.
• A lack of overall system of internal controls over financial reporting and disclosure controls and procedures, as identified by management, increases the risk of material misstatements and non-compliance.

Future Outlook

Management anticipates that future operations will generate positive cash flows starting in 2026. The company continues to evaluate opportunities in the United States where cannabis is legalized or rescheduled, and is actively seeking a joint venture partner or licensor for its Wisp Vaporizer and Wisp Pods in the US and Canadian legal cannabis or hemp markets.

Management Comments

• The Company is running its operations at its Simcoe Facility cultivating Premium Cannabis and started generating revenue (though its investment in JVCo) within the Canadian wholesale cannabis market.
• The continuation of the Company as a going concern is dependent upon these operations successfully generating cashflow for the Company, financial support from its stockholders, its ability to obtain necessary equity financing to continue operations and/or to successfully locate and negotiate with a business entity for the combination of the target company with the Company.
• Management is determining the value maintaining these patents will provide the Company. Once management has completed their assessment, the Company will proceed accordingly and advance in that determined direction moving forward.
• The management is of the view that no material losses will arise in respect of the legal claim at the date of these consolidated financial statements.
• The Company is actively seeking various financing operations to meet the working capital requirements.
• The Company anticipates that its future operations will generate positive cash flows starting in 2026.

Industry Context

StockSavvy.ai notes that Target Group Inc. operates within a highly dynamic and challenging Canadian cannabis market, characterized by persistent oversupply, price compression, and competition from the illicit market, as highlighted in the filing. The company's strategic focus on wholesale and co-packaging services, alongside cannabinoid research and product development, positions it to adapt to these conditions. The ongoing regulatory evolution in both Canada and the U.S., including the potential rescheduling of cannabis and narrowing of hemp definitions, presents both opportunities and significant risks for the company and the broader industry.

Comparison to Industry Standards

• The filing does not provide specific comparisons to industry benchmarks or comparable companies' financial results.
• The reported revenue decline and net loss contrast with the overall Canadian legal cannabis industry's cumulative nationwide sales of CDN$28.7 billion from October 2018 through 2024, suggesting Target Group Inc. may be underperforming relative to the broader market growth, or facing specific operational challenges not detailed in the context of industry averages.

Management Changes

Corporate Governance

Legal Proceedings

• A lawsuit was filed by a terminated employee of Canary against the Company for approximately $1,529,414 (CAD 2,100,000) in Ontario, Canada. The Company is defending its position and believes the ultimate decision will be in its favor.
• A complaint for damages of $150,000 was lodged against CannaKorp by its former Chief Financial Officer for outstanding professional fees. Management views that no material losses will arise.
• A claim for damages of approximately $95,245 (CAD 130,778) was lodged against Canary by a vendor for breach of contract. As of December 31, 2025, $100,795 (CAD 138,150) has been recorded in Canary's payable. Management views that no material losses will arise.

Related Party Transactions

• The CEO (Anthony Zarcone) is the secretary and a shareholder of CL Investors Inc. (CLI), and his brother is the President and sole director of CLI. CLI purchased a debt obligation from Canary to the Company for $2,115,840 (CAD 2,900,000).
• The Canary Debt, as amended, bears 5% interest per annum and matures 60 months from the Debt Agreement date (August 14, 2020). Repayment is guaranteed by Visava and CannaKorp and secured by a general security interest in assets and a pledge of stock.
• CLI has an option, in lieu of repayment, to demand transfer of 75% of Visava and Canary capital stock. The President of CLI (CEO's brother) has an option to acquire the remaining 25%.
• As of December 31, 2025, the company could not make repayments of certain debt owed to CLI and is in breach of the loan agreement, reclassifying the entire outstanding balance to current liabilities.
• Jerry Zarcone, the CEO's brother, provided a loan to the Company up to $2,032,943 (CAD 2,786,380) for working capital, secured by all company assets, with interest rates of 16% and 43.26%. The maturity date was extended to August 31, 2026.
• Outstanding management service fees owed to key officers (including CEO, VP, Controller) totaled $659,189 as of December 31, 2025.
• The company purchased $nil consulting services from GTA Angel Group (owned by CEO's brother) in 2025, with $24,733 outstanding.
• The company subleases its principal executive office from Norlandam Marketing Inc., a company owned by one of the directors (Saul Niddam).
• A subsequent event notes an additional loan of $240,768 (CAD 330,000) from the related party lender (Jerry Zarcone) with a 3.0146% monthly interest rate.

Stakeholder Impact

• Shareholders face significant dilution risk from potential future equity financing, especially given the going concern warning and increasing accumulated deficit. The unmaintained patents and breach of loan agreement could further erode shareholder value. The stock is a 'penny stock,' making it difficult to sell.
• Employees (40 as of December 31, 2025) may experience job insecurity and impacts on future compensation due to the company's financial distress and going concern issues.
• Customers could face potential disruption to product availability or quality if financial issues impact operations or the supply chain.
• Suppliers and creditors face increased risk of delayed or non-payment, particularly given the breach of a related party loan agreement and the reclassification of debt to current liabilities.
• Management faces significant challenges in addressing financial distress, securing financing, improving internal controls, and navigating legal proceedings.

Next Steps

• Management is determining the value of maintaining CannaKorp's unmaintained patents and will proceed accordingly once the assessment is complete.
• CannaKorp is actively seeking a joint venture partner and/or a licensor to assist in marketing and launching the Wisp Vaporizer and Wisp Pods in the US and Canadian legal cannabis or hemp markets.
• The company is under discussions to formalize arrangements with the related party lender (CL Investors Inc.) to revise the terms of the loans due to the breach of agreement.
• Management anticipates future operations will generate positive cash flows starting in 2026.
• The company will require additional working capital from either cash flow from operations, sale of its equity, or issuance of debt.
• The company entered into a Twelfth Amending Agreement with a related party lender for an additional $240,768 loan (subsequent event).

Key Dates

Recommendation

The company's 2025 annual report reveals severe financial deterioration, including a substantial net loss, a significant revenue decline, a growing working capital deficit, and a going concern warning from its independent auditors. The breach of a related party loan agreement, unmaintained intellectual property, and ineffective internal controls further highlight operational and financial instability. These factors, combined with the highly competitive and regulated cannabis market, present an extremely high-risk investment profile with a strong likelihood of further value erosion. A seasoned investor would likely view this as a strong sell due to the fundamental financial distress and significant uncertainties.

Keywords

Cannabis, Marijuana, SEC Filing, 10-K, Financial Report, Canada Cannabis Market, Cannabis Cultivation, Cannabis Processing, Cannabis Distribution, Vaporizer System, Wisp Pods, Serious Seeds, Going Concern, Working Capital Deficit, Net Loss, Revenue Decline, Related Party Transactions, Corporate Governance, Risk Factors, Internal Controls, OTC Markets, CBDY